University of Queensland researchers have developed a drug that activates a hard-to-target immune receptor—a breakthrough that could lead to new treatments for neurodegenerative conditions like motor neuron disease (MND).
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗